Conference abstract · 1 Dec 2016
PerspectivePublished 25 May 2022
Medications that Reduce Endothelial Activation Prevents the Spread of Experimental Cerebral Malaria
Subjects
Infectious DiseasesSimilar by topic
Commentary · 30 Sep 2024
Vaccination with Live Plasmodium yoelii 17XNL Strain Prevents Experimental Cerebral Malaria Development
Commentary · 24 Mar 2022
A Live Plasmodium yoelii 17XNL Vaccination Prevents the Development of Experimental Cerebral Malaria
Conference abstract · 2017
PLASMODIUM BERGHEI ADHERENCE AND ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN EXPERIMENTAL MALARIA-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME
Editorial · 30 Mar 2021
Cerebral Malaria - Causes and Prevention
More from this journal
The newest in Malaria Control & Elimination.
Perspective · 29 Nov 2025
Combating Residual Malaria: A Multi-Pronged Approach
Perspective · 29 Nov 2025
Entomological Surveillance: Guiding Malaria Control Efforts
Short communication · 29 Nov 2025
Climate Change Alters Malaria Vector Ecology and Risk
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMalaria Control & Elimination
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Ambrose Otau Talisuna”

